Want to join the conversation?
$ISRG generated approx. $13MM of revenue in 3Q16 from leased buyouts compared with $3MM in 3Q15. The company expects the level of 4Q16 buyouts to be below 3Q16. $ISRG generated approx. $4MM of revenue associated with operating leases in 3Q16 compared with $2MM in 3Q15.
Biodefense therapeutics firm $PIP announced an all-stock merger with biotech Altimmune. The respective boards of the two companies unanimously approved the merger.
$YHOO is reporting today after market close. Nobody cares about this stock.